Terms ending in 2039
Every in-force patent on Bayer AG's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,564,392 | Methods of Inactivation of Viruses Using N-Methlyglucamide and Its Derivatives In force · High confidence | Bayer Healthcare LLC | In force | High confidence | |
| US 11,696,576 | Pest Control System and Associated Method In force · High confidence | Discovery Purchaser Corporation | In force | High confidence | |
| US 11,597,901 | Adapter for Cell-Culture Vessel In force · High confidence | Bayer Aktiengesellschaft and Bayer Healthcare LLC | In force | High confidence | |
| US 11,934,996 | Monitoring of Products In force · High confidence | Bayer Aktiengesellschaft | In force | High confidence | |
| US 11,934,997 | Monitoring of Products In force · High confidence | Bayer Aktiengesellschaft | In force | High confidence | |
| US 11,934,998 | Monitoring of Products In force · High confidence | Bayer Aktiengesellschaft | In force | High confidence | |
| US 11,934,999 | Monitoring of Products In force · High confidence | Bayer Aktiengesellschaft | In force | High confidence | |
| US 12,299,519 | Monitoring of Products In force · High confidence | Bayer Aktiengesellschaft | In force | High confidence | |
| US 11,524,944 | 2-Phenylpyrimidine-4-Carboxamides as Ahr Inhibitors In force · High confidence | Deutsches Krebsforschungszentrum | In force | High confidence | |
| US 11,856,937 | Apparatus for Weed Control In force · High confidence | Discovery Purchaser Corporation | In force | High confidence | |
| 48 more term ends in 2039 · Pro | |||||
10 of 58 patents shown. Soonest term end first, then patent number.
Pro members see all 58.
48 of these are in force and held by Bayer AG.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.